Rapidly progressing primary splenic angiosarcoma with fatal hemorrhagic event-Reference-Cited by-同舟云学术

Rapidly progressing primary splenic angiosarcoma with fatal hemorrhagic event

Published:2013-12-06 Issue:4 Volume:26 Page:248-252
ISSN:1120-009X
Container-title:Journal of Chemotherapy
language:en
Short-container-title:Journal of Chemotherapy

Author:

Cho Eun Ae,Choi Won-Young,Kim Seung-Hun,Hong Ji-Yun,Jung Sung-Hoon,Kim Min-Jee,Hwang Jun-Eul,Bae Woo-Kyun,Shim Hyun-Jeong,Lee Kyung-Hwa,Cho Sang-Hee,Chung Ik-Joo

Publisher

Informa UK Limited

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology,Oncology

Link

http://www.tandfonline.com/doi/pdf/10.1080/10256018808623883

Reference14 articles.

1. Angiosarcoma

2. Paclitaxel as Neoadjuvant Therapy for High Grade Angiosarcoma of the Spleen: A Brief Report and Literature Review

3. Primary angiosarcoma of the spleen

4. Long-term Survival of a Patient with Splenic Angiosarcoma after Resection, High-dose Chemotherapy, and Autologous Peripheral Blood Stem Cell Transplantation

5. Primary Splenic Angiosarcoma

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment with sorafenib plus camrelizumab after splenectomy for primary splenic angiosarcoma with liver metastasis: A case report and literature review;World Journal of Clinical Cases;2022-03-26

2. Treatment with sorafenib plus camrelizumab after splenectomy for primary splenic angiosarcoma with liver metastasis: A case report and literature review;World Journal of Clinical Cases;2022-03-26

3. Long-Term Survival due to Chemotherapy including Paclitaxel in a Patient with Metastatic Primary Splenic Angiosarcoma;Case Reports in Gastroenterology;2021-10-11

4. Spleen angiosarcoma: a world review;Expert Review of Gastroenterology & Hepatology;2021-07-22